BE between one injection vs multiple injection products [Design Issues]

posted by weiguo2122 – 2024-06-27 17:07 (304 d 17:44 ago) – Posting: # 24044
Views: 1,545

That should not be a BE study? Then what should be considered when we develop product from daily injection to weekly as well as weekly to monthly?


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
89 visitors (0 registered, 89 guests [including 6 identified bots]).
Forum time: 10:51 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5